An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu

NCT02678234 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The clinical phase of the study (from FSFV to LSLV) was never initiated due to the sponsor's decision.

Conditions

Interventions

Sponsor

GlaxoSmithKline